Baillie Gifford - PUMA BIOTECHNOLOGY INC ownership

PUMA BIOTECHNOLOGY INC's ticker is PBYI and the CUSIP is 74587V107. A total of 118 filers reported holding PUMA BIOTECHNOLOGY INC in Q3 2021. The put-call ratio across all filers is 0.48 and the average weighting 0.1%.

Quarter-by-quarter ownership
Baillie Gifford ownership history of PUMA BIOTECHNOLOGY INC
ValueSharesWeighting
Q3 2021$2,0000.0%2520.0%0.00%
Q2 2021$2,0000.0%2520.0%0.00%
Q1 2021$2,000
-33.3%
2520.0%0.00%
Q4 2020$3,0002520.00%
Other shareholders
PUMA BIOTECHNOLOGY INC shareholders Q3 2021
NameSharesValueWeighting ↓
EcoR1 Capital, LLC 2,536,156$21,405,0002.24%
Palo Alto Investors LP 1,396,163$11,784,0000.99%
Camber Capital Management LP 1,950,000$16,458,0000.98%
TANG CAPITAL MANAGEMENT LLC 800,000$6,752,0000.95%
Capital Impact Advisors, LLC 147,303$1,243,0000.52%
Sofinnova Investments, Inc. 638,026$5,385,0000.50%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 963,212$8,130,0000.26%
RICE HALL JAMES & ASSOCIATES, LLC 466,482$3,937,0000.22%
PDT Partners, LLC 204,238$1,724,0000.14%
Eversept Partners, LP 58,251$491,6380.12%
View complete list of PUMA BIOTECHNOLOGY INC shareholders